Drug:
Reaction: DRUG INEFFECTIVE
20250101 - 20251231
No. 301 - 400
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 301 | 25142775 |
US |
73 | 2 |
Drug ineffective, Off label use, |
||||
LENALIDOMIDE, |
||||
| 302 | 25142788 |
PR |
72 | 2 |
Drug ineffective, Platelet count decreased, |
||||
LENALIDOMIDE, LENALIDOMIDE, |
||||
| 303 | 25142790 |
US |
||
Drug ineffective, |
||||
LINACLOTIDE, |
||||
| 304 | 25144810 |
|||
Drug ineffective, |
||||
PHENTERMINE HYDROCHLORIDE, |
||||
| 305 | 25146380 |
|||
Drug ineffective, Product use issue, Withdrawal syndrome, Feeling drunk, Gait disturbance, |
||||
AMANTADINE, |
||||
| 306 | 25146686 |
34 | 1 | |
Drug ineffective, Therapy change, |
||||
BUPRENORPHINE, |
||||
| 307 | 25138149 |
US |
2 | |
Drug ineffective, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 308 | 25138185 |
US |
2 | |
Sleep disorder due to a general medical condition, Drug ineffective, |
||||
DUPILUMAB, SERTRALINE HYDROCHLORIDE, |
||||
| 309 | 25138223 |
US |
24 | 1 |
Drug ineffective, |
||||
MIRIKIZUMAB-MRKZ, MIRIKIZUMAB-MRKZ, |
||||
| 310 | 25138236 |
US |
75 | 1 |
Muscle tightness, Drug ineffective, |
||||
SARILUMAB, CARBIDOPA AND LEVODOPA, |
||||
| 311 | 25138244 |
AT |
70 | |
Drug ineffective, Cytopenia, Renal impairment, |
||||
TECLISTAMAB, |
||||
| 312 | 25138256 |
US |
77 | 2 |
Drug ineffective, Nausea, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 313 | 25138319 |
US |
||
Drug ineffective, |
||||
TIRZEPATIDE, |
||||
| 314 | 25138339 |
US |
76 | 2 |
Psoriatic arthropathy, Rheumatoid arthritis, Urinary tract infection, Chronic obstructive pulmonary disease, Night sweats, Abdominal pain upper, Drug ineffective, Gastrointestinal pain, |
||||
GUSELKUMAB, GUSELKUMAB, FLUCONAZOLE, |
||||
| 315 | 25138353 |
US |
||
Product storage error, Injection site rash, Drug ineffective, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
| 316 | 25138458 |
US |
40 | 2 |
Increased appetite, Weight increased, Drug ineffective, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 317 | 25138646 |
US |
||
Poor quality product administered, Drug ineffective, Product preparation error, |
||||
ONABOTULINUMTOXINA, ONABOTULINUMTOXINA, ONABOTULINUMTOXINA, ONABOTULINUMTOXINA, |
||||
| 318 | 25138662 |
US |
59 | 2 |
Drug ineffective, |
||||
TIRZEPATIDE, |
||||
| 319 | 25138665 |
US |
26 | 2 |
Pruritus, Dry skin, Skin exfoliation, Drug ineffective, |
||||
DUPILUMAB, |
||||
| 320 | 25138694 |
US |
2 | |
Drug ineffective, |
||||
QUETIAPINE FUMARATE, QUETIAPINE, |
||||
| 321 | 25138724 |
US |
1 | |
Drug ineffective, |
||||
QUETIAPINE FUMARATE, QUETIAPINE, |
||||
| 322 | 25138725 |
AU |
45 | 2 |
Oedema peripheral, Drug ineffective, |
||||
QUETIAPINE FUMARATE, QUETIAPINE, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, VALPROATE SODIUM, VALPROATE SODIUM, DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), MORPHINE, ROSUVASTATIN, |
||||
| 323 | 25138728 |
AU |
62 | 1 |
Off label use, Drug ineffective, |
||||
QUETIAPINE FUMARATE, QUETIAPINE, CITALOPRAM, CITALOPRAM HYDROBROMIDE, NORTRIPTYLINE HYDROCHLORIDE, SERTRALINE HYDROCHLORIDE, |
||||
| 324 | 25138731 |
US |
||
Drug ineffective, |
||||
QUETIAPINE FUMARATE, QUETIAPINE, BUPROPION HYDROCHLORIDE, BUPROPION, |
||||
| 325 | 25138738 |
US |
||
Off label use, Drug ineffective, |
||||
TIRZEPATIDE, |
||||
| 326 | 25138743 |
IT |
27 | 2 |
Drug ineffective, |
||||
QUETIAPINE FUMARATE, QUETIAPINE, QUETIAPINE FUMARATE, QUETIAPINE, QUETIAPINE FUMARATE, QUETIAPINE, QUETIAPINE FUMARATE, QUETIAPINE, QUETIAPINE FUMARATE, QUETIAPINE, QUETIAPINE FUMARATE, QUETIAPINE, OXCARBAZEPINE, OXCARBAZEPINE, OXCARBAZEPINE, OXCARBAZEPINE, OXCARBAZEPINE, OXCARBAZEPINE, HALOPERIDOL, HALOPERIDOL LACTATE, HALOPERIDOL, HALOPERIDOL LACTATE, HALOPERIDOL, HALOPERIDOL LACTATE, HALOPERIDOL, HALOPERIDOL LACTATE, HALOPERIDOL, HALOPERIDOL LACTATE, HALOPERIDOL, HALOPERIDOL LACTATE, RISPERIDONE, RISPERIDONE, RISPERIDONE, RISPERIDONE, RISPERIDONE, RISPERIDONE, VALPROIC ACID, VALPROIC ACID, VALPROIC ACID, VALPROIC ACID, VALPROIC ACID, VALPROIC ACID, |
||||
| 327 | 25141321 |
19 | 2 | |
Drug ineffective, |
||||
METHYLPREDNISOLONE, METHYLPREDNISOLONE, |
||||
| 328 | 25137207 |
CA |
32 | 2 |
Abdominoplasty, Abdominal wall disorder, COVID-19, Dysphonia, Oropharyngeal pain, Back pain, COVID-19, Streptococcal bronchitis, Cough, Sputum discoloured, Mammoplasty, Drug ineffective, Constipation, Anal fissure haemorrhage, Anal fistula, Migraine, Pain, Diarrhoea haemorrhagic, Urticaria, Swollen tongue, Influenza like illness, Streptococcal infection, Tonsillitis streptococcal, Pharyngitis streptococcal, Procedural pain, Incorrect product administration duration, Glossodynia, Tongue erythema, Glossitis, Fatigue, Vitamin B12 deficiency, Faeces hard, Secretion discharge, Oligomenorrhoea, Lichen sclerosus, Lichen planus, Pain in extremity, Dizziness, Off label use, Blood pressure decreased, Pneumonia, Cystitis, Sputum discoloured, Mood altered, Increased appetite, Hypotension, Nasal congestion, Mammoplasty, Back pain, Anal pruritus, |
||||
INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, NIRMATRELVIR AND RITONAVIR, POLYETHYLENE GLYCOL (3350), POLYETHYLENE GLYCOL 3350, POLYETHYLENE GLYCOL 400, |
||||
| 329 | 25137259 |
CA |
40 | 1 |
Disinhibition, Antipsychotic drug level below therapeutic, Obsessive-compulsive disorder, Toxicity to various agents, Schizoaffective disorder, Irritability, Prescribed overdose, Off label use, Dyslipidaemia, Leukaemia, Product use in unapproved indication, Obesity, Suicide attempt, Euphoric mood, Akathisia, Increased appetite, Leukopenia, Weight increased, Therapeutic product effect incomplete, Therapeutic product effect variable, Drug ineffective, Hypertension, |
||||
CITALOPRAM, CITALOPRAM HYDROBROMIDE, CITALOPRAM, CITALOPRAM HYDROBROMIDE, ASENAPINE MALEATE, ASENAPINE MALEATE, FLUOXETINE HYDROCHLORIDE, AMISULPRIDE, AMISULPRIDE, CLOMIPRAMINE HYDROCHLORIDE, CLOMIPRAMINE HYDROCHLORIDE CAPSULES, CLOZAPINE, GABAPENTIN, GABAPENTIN, GABAPENTIN, HALOPERIDOL, HALOPERIDOL LACTATE, HALOPERIDOL, HALOPERIDOL LACTATE, HALOPERIDOL, HALOPERIDOL LACTATE, LITHIUM CARBONATE, LITHIUM CARBONATE, LITHIUM CARBONATE, LITHIUM, LITHIUM BROMATUM, LITHIUM, LITHIUM BROMATUM, LITHIUM, LITHIUM BROMATUM, OLANZAPINE, OLANZAPINE, OLANZAPINE, OLANZAPINE, PERPHENAZINE, PERPHENAZINE, PERPHENAZINE, PERPHENAZINE, RISPERIDONE, RISPERIDONE, RISPERIDONE, RISPERIDONE, RISPERIDONE, TRIFLUOPERAZINE HYDROCHLORIDE, TRIFLUOPERAZINE HYDROCHLORIDE, QUETIAPINE FUMARATE, QUETIAPINE, QUETIAPINE FUMARATE, QUETIAPINE, QUETIAPINE FUMARATE, QUETIAPINE, QUETIAPINE FUMARATE, QUETIAPINE, QUETIAPINE FUMARATE, QUETIAPINE, QUETIAPINE FUMARATE, QUETIAPINE, FLUOXETINE HYDROCHLORIDE, ZIPRASIDONE, ARIPIPRAZOLE, VALPROATE SODIUM, VALPROATE SODIUM, OLANZAPINE, ZIPRASIDONE, FLUOXETINE HYDROCHLORIDE, FLUOXETINE, LOXAPINE, ZIPRASIDONE MESYLATE, |
||||
| 330 | 25137310 |
US |
2 | |
Drug ineffective, |
||||
ONABOTULINUMTOXINA, ONABOTULINUMTOXINA, ONABOTULINUMTOXINA, ONABOTULINUMTOXINA, ONABOTULINUMTOXINA, ONABOTULINUMTOXINA, |
||||
| 331 | 25137324 |
US |
72 | 1 |
Pneumonia, Drug ineffective, Dyskinesia, Speech disorder, Gait disturbance, |
||||
DEUTETRABENAZINE, DIVALPROEX SODIUM, ALFUZOSIN HYDROCHLORIDE, FINASTERIDE, MELATONIN, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, QUETIAPINE FUMARATE, QUETIAPINE, SODIUM BICARBONATE, SODIUM BICARBONATE INJECTION,, ERGOCALCIFEROL, AMLODIPINE BESYLATE, BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, DAPAGLIFLOZIN, HYDROXYZINE, LEVOTHYROXINE, LISINOPRIL, |
||||
| 332 | 25137339 |
CA |
2 | |
Obstruction, Drug ineffective, |
||||
UPADACITINIB, |
||||
| 333 | 25137412 |
CA |
43 | |
Asthma, Drug ineffective, |
||||
BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, IPRATROPIUM BROMIDE, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, EPINEPHRINE, ADRENALINUM, FLUTICASONE FUROATE, ALBUTEROL SULFATE, ALBUTEROL, TIOTROPIUM BROMIDE, |
||||
| 334 | 25137456 |
US |
2 | |
Drug ineffective, |
||||
FUROSEMIDE, FUROSEMIDE, |
||||
| 335 | 25137497 |
AU |
50 | 1 |
Aspergillus infection, Drug ineffective, Scedosporium infection, |
||||
TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, METHYLPREDNISOLONE, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, |
||||
| 336 | 25137518 |
CN |
40 | 2 |
Disease progression, Drug ineffective, |
||||
BEVACIZUMAB, BEVACIZUMAB, |
||||
| 337 | 25137530 |
AU |
27 | 2 |
Infection, Renal failure, Drug ineffective, |
||||
MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, ENALAPRIL, FUROSEMIDE, METHYLDOPA, |
||||
| 338 | 25137548 |
US |
62 | 2 |
Skin disorder, Psoriasis, Drug ineffective, Pruritus, |
||||
ADALIMUMAB, AMLODIPINE, |
||||
| 339 | 25137549 |
BR |
||
Ankylosing spondylitis, Impaired work ability, Pain, Head discomfort, Insomnia, Fatigue, Therapeutic response changed, Product substitution issue, Drug ineffective, |
||||
INFLIXIMAB-DYYB, INFLIXIMAB, METHOTREXATE SODIUM, |
||||
| 340 | 25137559 |
US |
38 | 1 |
Impaired quality of life, Drug ineffective, |
||||
DUPILUMAB, BUDESONIDE, FLUTICASONE PROPIONATE, LISINOPRIL, MONTELUKAST, CETIRIZINE HYDROCHLORIDE, |
||||
| 341 | 25137586 |
US |
2 | |
Drug ineffective, |
||||
NICOTINE POLACRILEX, NICOTINE, NICOTINE POLACRILEX MINI, NICOTINE POLARILEX, |
||||
| 342 | 25137597 |
US |
37 | 1 |
Drug ineffective, |
||||
CLOPIDOGREL, CLOPIDOGREL BISULFATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, APIXABAN, |
||||
| 343 | 25137608 |
US |
47 | |
Drug ineffective, |
||||
ONABOTULINUMTOXINA, |
||||
| 344 | 25137650 |
US |
56 | 2 |
Off label use, Drug ineffective, |
||||
DEUTETRABENAZINE, |
||||
| 345 | 25137670 |
US |
32 | 1 |
Drug ineffective, |
||||
BIVALIRUDIN, APIXABAN, APIXABAN, |
||||
| 346 | 25137671 |
US |
53 | 1 |
Hypoxia, Respiratory failure, Drug ineffective, |
||||
NICARDIPINE HYDROCHLORIDE, NICARDIPINE, FUROSEMIDE, NICARDIPINE HYDROCHLORIDE, NICARDIPINE, |
||||
| 347 | 25137673 |
BR |
1 | |
Product storage error, Stress, Feeling abnormal, Drug ineffective, Disturbance in attention, Nervousness, |
||||
FLUVOXAMINE MALEATE, ALPRAZOLAM, FLUVOXAMINE MALEATE, FLUVOXAMINE MALEATE, FLUVOXAMINE MALEATE, FLUVOXAMINE MALEATE, FLUVOXAMINE MALEATE, |
||||
| 348 | 25137674 |
DE |
50 | 2 |
Epilepsy, Road traffic accident, Off label use, Drug ineffective, |
||||
LACOSAMIDE, LACOSAMIDE, LACOSAMIDE, LEVETIRACETAM, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, LEVETIRACETAM IN SODIUM CHLORIDE, LEVETIRACETAM, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, LEVETIRACETAM IN SODIUM CHLORIDE, |
||||
| 349 | 25137675 |
US |
54 | 1 |
Parkinsonism, Drug ineffective, |
||||
LORAZEPAM, RISPERIDONE, LITHIUM, LITHIUM BROMATUM, CARBAMAZEPINE, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, SERTRALINE, QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, PROPRANOLOL HYDROCHLORIDE, SERTRALINE, LORAZEPAM, LORAZEPAM, |
||||
| 350 | 25137704 |
US |
1 | |
Pneumonia, Septic shock, Respiratory disorder, Drug ineffective, |
||||
PREDNISONE, PYRIDOSTIGMINE BROMIDE, PEMBROLIZUMAB, METHYLPREDNISOLONE, |
||||
| 351 | 25137725 |
FR |
53 | 2 |
Feeling abnormal, Fatigue, Retinal vein occlusion, Anaemia, Road traffic accident, Fall, Craniocerebral injury, Vertigo, Cervical vertebral fracture, Back disorder, Hand dermatitis, Deafness, Dyspnoea, Dizziness, Chest pain, Inappropriate schedule of product administration, Mouth ulceration, Influenza, Eczema, Fear of falling, Drug intolerance, Tachycardia, Pain in extremity, Fear, Polyuria, Drug ineffective, Dry mouth, Lip injury, Serum ferritin decreased, |
||||
SPIRONOLACTONE, |
||||
| 352 | 25137730 |
US |
19 | 2 |
Drug ineffective, Dysarthria, Somnolence, Tachycardia, Off label use, |
||||
NEOSTIGMINE, ATROPINE SULFATE, ATROPINE, NASAL, SALINE, (SALINE), |
||||
| 353 | 25137761 |
US |
2 | |
Illness, Skin plaque, Drug ineffective, |
||||
RISANKIZUMAB-RZAA, |
||||
| 354 | 25137778 |
GR |
28 | 2 |
Hallucination, auditory, Weight increased, Amenorrhoea, Feeling abnormal, Drug ineffective, |
||||
OLANZAPINE, OLANZAPINE, RISPERIDONE, RISPERIDONE, |
||||
| 355 | 25137782 |
PL |
59 | 1 |
Subcutaneous haematoma, Vascular pseudoaneurysm, Drug ineffective, |
||||
RIVAROXABAN, |
||||
| 356 | 25137794 |
US |
32 | 1 |
Hospitalisation, Drug resistance, Drug ineffective, |
||||
DIVALPROEX SODIUM, LITHIUM, LITHIUM BROMATUM, CLOZAPINE, CLONAZEPAM, OLANZAPINE, OLANZAPINE PAMOATE, ZIPRASIDONE HYDROCHLORIDE, ZIPRASIDONE, ZIPRASIDONE MESYLATE, HALOPERIDOL, HALOPERIDOL LACTATE, TEMAZEPAM, |
||||
| 357 | 25137854 |
US |
65 | 2 |
Peripheral swelling, Musculoskeletal stiffness, Product quality issue, Drug ineffective, Back pain, Arthralgia, |
||||
ADALIMUMAB, PREDNISONE, METHOTREXATE, METHOTREXATE SODIUM, |
||||
| 358 | 25137940 |
CA |
||
Neuromyelitis optica spectrum disorder, Anal incontinence, Urinary incontinence, Drug ineffective, |
||||
RITUXIMAB, |
||||
| 359 | 25137960 |
US |
2 | |
Dyspnoea, Chills, Tremor, Hypoaesthesia, Heart rate increased, Dry mouth, Myalgia, Oropharyngeal pain, Intentional underdose, Drug ineffective, |
||||
FLUTICASONE PROPIONATE AND SALMETEROL, FLUTICASONE PROPIONATE AND SALMETEROL, |
||||
| 360 | 25138027 |
US |
1 | |
Drug ineffective, |
||||
DUPILUMAB, ERGOCALCIFEROL, TURMERIC, SOAP, OIL, |
||||
| 361 | 25138035 |
US |
2 | |
Drug ineffective, |
||||
DUPILUMAB, |
||||
| 362 | 25138051 |
US |
63 | 2 |
Drug ineffective, Rheumatoid arthritis, |
||||
ABATACEPT, |
||||
| 363 | 25138074 |
US |
66 | 2 |
Drug ineffective, |
||||
DUPILUMAB, ANASTROZOLE, ANASTROZOLE TABLETS, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, |
||||
| 364 | 25138078 |
US |
38 | 2 |
Drug ineffective, |
||||
DAPTOMYCIN, |
||||
| 365 | 25132079 |
US |
59 | 1 |
Rheumatoid arthritis, Drug ineffective, |
||||
BIMEKIZUMAB, MONTELUKAST SODIUM, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, ROSUVASTATIN CALCIUM, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, |
||||
| 366 | 25132138 |
71 | 1 | |
Somnolence, Drug ineffective, Product use issue, |
||||
SOLRIAMFETOL, NEBIVOLOL HYDROCHLORIDE, BUPROPION HYDROCHLORIDE, BUPROPION, GABAPENTIN, |
||||
| 367 | 25132149 |
US |
43 | 1 |
Drug ineffective, |
||||
OZANIMOD HYDROCHLORIDE, |
||||
| 368 | 25132207 |
US |
2 | |
Drug ineffective, Treatment noncompliance, Genotype drug resistance test positive, |
||||
ELVITEGRAVIR, COBICISTAT, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE, |
||||
| 369 | 25132208 |
US |
55 | 1 |
Drug ineffective, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 370 | 25132223 |
US |
41 | 1 |
Hunger, Drug ineffective, Blood glucose increased, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 371 | 25132233 |
CN |
||
Cardiac failure, Hyperkalaemia, Atrial fibrillation, Blood creatinine increased, Drug ineffective, |
||||
METOPROLOL TARTRATE, METOPROLOL, BISOPROLOL FUMARATE, ISOSORBIDE MONONITRATE, AMLODIPINE, FELODIPINE, FELODIPINE EXTENDED-RELEASE TABLETS, DIGOXIN, |
||||
| 372 | 25132255 |
US |
72 | 2 |
Dry throat, Drug ineffective, |
||||
FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, DEXTROMETHORPHAN HYDROBROMIDE AND GUAIFENESIN, CAMPHOR (NATURAL), EUCALYPTUS OIL, AND MENTHOL, UNSPECIFIED FORM, DEXTROMETHORPHAN, ACETAMINOPHEN AND DEXTROMETHORPHAN HYDROBROMIDE, METHOCARBAMOL, METHOCARBAMOL TABLETS, |
||||
| 373 | 25132257 |
US |
||
Drug ineffective, Asthma-chronic obstructive pulmonary disease overlap syndrome, |
||||
BENRALIZUMAB, |
||||
| 374 | 25132271 |
US |
||
Drug ineffective, |
||||
CETIRIZINE HYDROCHLORIDE, |
||||
| 375 | 25132313 |
US |
2 | |
Injection site pain, Drug ineffective, |
||||
DUPILUMAB, DUPILUMAB, THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE, ZINC, ZINC GLUCONATE, ZINC CHLORIDE, ERGOCALCIFEROL, VITAMIN C, MAGNESIUM, FEXOFENADINE HYDROCHLORIDE, ESOMEPRAZOLE MAGNESIUM, |
||||
| 376 | 25132331 |
US |
||
Disease progression, Drug intolerance, Drug ineffective, |
||||
BEVACIZUMAB, |
||||
| 377 | 25132358 |
US |
1 | |
Dehydration, Headache, Drug ineffective, |
||||
| 378 | 25132377 |
US |
||
Drug ineffective, No adverse event, |
||||
FARICIMAB, |
||||
| 379 | 25132424 |
US |
2 | |
Drug ineffective, Diarrhoea, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 380 | 25132428 |
US |
||
Dry mouth, Flatulence, Drug ineffective, Product formulation issue, |
||||
CELECOXIB, |
||||
| 381 | 25132431 |
US |
2 | |
Drug ineffective, |
||||
FEXOFENADINE HYDROCHLORIDE, FEXOFENADINE HYDROCHLORIDE ORAL, FEXOFENADINE HCL, FEXOFENADINE HYDROCHLORIDE, FEXOFENADINE HYDROCHLORIDE ORAL, FEXOFENADINE HCL, FEXOFENADINE HYDROCHLORIDE, FEXOFENADINE HYDROCHLORIDE ORAL, FEXOFENADINE HCL, FEXOFENADINE HYDROCHLORIDE, FEXOFENADINE HYDROCHLORIDE ORAL, FEXOFENADINE HCL, |
||||
| 382 | 25132435 |
US |
55 | 1 |
Drug ineffective, Product substitution issue, |
||||
CELECOXIB, |
||||
| 383 | 25132455 |
US |
2 | |
Drug ineffective, |
||||
CELECOXIB, CELECOXIB, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, |
||||
| 384 | 25132461 |
US |
75 | 1 |
Drug ineffective, |
||||
EMPAGLIFLOZIN, DULAGLUTIDE, |
||||
| 385 | 25132485 |
US |
2 | |
Drug ineffective, |
||||
DUPILUMAB, |
||||
| 386 | 25132526 |
US |
||
Drug ineffective, |
||||
ESOMEPRAZOLE MAGNESIUM, |
||||
| 387 | 25132548 |
US |
39 | 2 |
Dysgeusia, Drug ineffective, |
||||
NICOTINE POLACRILEX, |
||||
| 388 | 25132552 |
US |
1 | |
Drug ineffective, Dyskinesia, |
||||
DEUTETRABENAZINE, |
||||
| 389 | 25132568 |
US |
30 | 2 |
Insomnia, Anxiety disorder, Condition aggravated, Drug ineffective, |
||||
ESZOPICLONE, SERTRALINE, HYDROXYZINE, |
||||
| 390 | 25132591 |
US |
1 | |
Drug ineffective, |
||||
DUPILUMAB, AMLODIPINE, APIXABAN, FUROSEMIDE, LEVOTHYROXINE, LOSARTAN POTASSIUM, LOSARTAN, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, MOXIFLOXACIN HYDROCHLORIDE, MOXIFLOXACIN, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, TORSEMIDE, |
||||
| 391 | 25132618 |
US |
||
Drug ineffective, Nausea, |
||||
DULAGLUTIDE, |
||||
| 392 | 25132649 |
US |
63 | 1 |
Drug ineffective, |
||||
TRALOKINUMAB-LDRM, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, EMPAGLIFLOZIN, GLIMEPIRIDE, LORATADINE, INSULIN GLARGINE, ALLOPURINOL, LISINOPRIL, GEMFIBROZIL, |
||||
| 393 | 25132660 |
US |
||
Drug ineffective, Drug ineffective for unapproved indication, Underdose, Off label use, |
||||
| 394 | 25132722 |
AU |
22 | 2 |
Drug ineffective, Drug intolerance, |
||||
SIMVASTATIN, |
||||
| 395 | 25132735 |
FR |
||
Drug ineffective, |
||||
AZACITIDINE, AZACITIDINE FOR, |
||||
| 396 | 25132758 |
FR |
||
Drug ineffective, |
||||
AZACITIDINE, AZACITIDINE FOR, |
||||
| 397 | 25132761 |
FR |
||
Drug ineffective, |
||||
AZACITIDINE, AZACITIDINE FOR, |
||||
| 398 | 25132779 |
FR |
||
Drug ineffective, |
||||
AZACITIDINE, AZACITIDINE FOR, |
||||
| 399 | 25132782 |
US |
72 | 1 |
Drug ineffective, Low density lipoprotein increased, |
||||
EVOLOCUMAB, EZETIMIBE, |
||||
| 400 | 25132794 |
US |
68 | 2 |
Drug ineffective, Psoriasis, |
||||
IXEKIZUMAB, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-04-28